{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=ParaGard%C2%AE", "query": { "intervention": "ParaGard®" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 6, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-22T03:59:11.843Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03124160", "title": "Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Healthy Women", "Female Contraception" ], "interventions": [ { "name": "Mona Lisa® NT Cu380 Mini", "type": "DRUG" }, { "name": "ParaGard® TCu380A", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "FHI 360", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "16 Years", "maximum_age": "40 Years", "sex": "FEMALE", "summary": "16 Years to 40 Years · Female only" }, "enrollment_count": 1105, "start_date": "2017-05-26", "completion_date": "2022-06-06", "has_results": true, "last_update_posted_date": "2024-09-25", "last_synced_at": "2026-09-22T03:59:11.843Z", "location_count": 16, "location_summary": "Los Angeles, California • Sacramento, California • San Francisco, California + 11 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Honolulu", "state": "Hawaii" } ], "official_url": "https://clinicaltrials.gov/study/NCT03124160" }, { "nct_id": "NCT05309694", "title": "A Study to Assess the Safety of a New Inserter Device for Paragard® (Intrauterine Copper Contraceptive)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Contraception" ], "interventions": [ { "name": "Paragard® T380A Intrauterine Copper Contraceptive with New Inserter", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "CooperSurgical Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 119, "start_date": "2022-03-04", "completion_date": "2022-12-08", "has_results": true, "last_update_posted_date": "2026-08-25", "last_synced_at": "2026-09-22T03:59:11.843Z", "location_count": 8, "location_summary": "Denver, Colorado • South Miami, Florida • Atlanta, Georgia + 4 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "South Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Saginaw", "state": "Michigan" }, { "city": "Franklin", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05309694" }, { "nct_id": "NCT03785366", "title": "A PK Study Comparing VeraCept vs. ParaGard Intrauterine Devices (IUDs)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Women at Risk for Pregnancy" ], "interventions": [ { "name": "VeraCept", "type": "DRUG" }, { "name": "ParaGard", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sebela Women's Health Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "45 Years", "sex": "FEMALE", "summary": "Up to 45 Years · Female only" }, "enrollment_count": 41, "start_date": "2018-12-17", "completion_date": "2024-08-01", "has_results": true, "last_update_posted_date": "2025-08-15", "last_synced_at": "2026-09-22T03:59:11.843Z", "location_count": 2, "location_summary": "Portland, Oregon • Seattle, Washington", "locations": [ { "city": "Portland", "state": "Oregon" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT03785366" }, { "nct_id": "NCT02391714", "title": "Nitrous Oxide for Pain Management of Intrauterine Device (IUD) Insertion", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Contraception" ], "interventions": [ { "name": "IUD insertion", "type": "PROCEDURE" }, { "name": "Povidone-Iodine", "type": "DRUG" }, { "name": "Chlorhexidine", "type": "DRUG" }, { "name": "Oxygen", "type": "OTHER" }, { "name": "Nitrous oxide", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "University of New Mexico", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "FEMALE", "summary": "12 Years and older · Female only" }, "enrollment_count": 80, "start_date": "2013-10", "completion_date": "2014-08", "has_results": true, "last_update_posted_date": "2016-02-03", "last_synced_at": "2026-09-22T03:59:11.843Z", "location_count": 1, "location_summary": "Albuquerque, New Mexico", "locations": [ { "city": "Albuquerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT02391714" }, { "nct_id": "NCT01299116", "title": "Long-Acting Reversible Contraception", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Contraception" ], "interventions": [ { "name": "DMPA", "type": "DRUG" }, { "name": "oral contraceptives", "type": "DRUG" }, { "name": "Implanon®", "type": "DRUG" }, { "name": "ParaGard®", "type": "DRUG" }, { "name": "Mirena®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "FHI 360", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "29 Years", "sex": "FEMALE", "summary": "18 Years to 29 Years · Female only" }, "enrollment_count": 916, "start_date": "2011-12", "completion_date": "2016-12", "has_results": true, "last_update_posted_date": "2018-02-28", "last_synced_at": "2026-09-22T03:59:11.843Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01299116" }, { "nct_id": "NCT02357368", "title": "Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "HIV", "Contraception" ], "interventions": [ { "name": "Depot medroxyprogesterone acetate (DMPA)", "type": "DRUG" }, { "name": "Etonogestrel implant (Eng-Implant)", "type": "DEVICE" }, { "name": "Levonorgestrel intrauterine device (Lng-IUD)", "type": "DEVICE" }, { "name": "ParaGard® T 380A Intrauterine Copper Contraceptive", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Lisa Haddad", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "18 Years to 45 Years · Female only" }, "enrollment_count": 59, "start_date": "2015-02", "completion_date": "2019-10-23", "has_results": true, "last_update_posted_date": "2020-11-18", "last_synced_at": "2026-09-22T03:59:11.843Z", "location_count": 4, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02357368" } ] }